J Med Genet

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Published Online First: 3 October 2006. doi:10.1136/jmg.2006.045153
Journal of Medical Genetics 2007;44:44-50
Copyright © 2007 by the BMJ Publishing Group Ltd.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jmg.2006.045153v1
44/1/44    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Andresen, J M
Right arrow Articles by Wexler, N S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Andresen, J M
Right arrow Articles by Wexler, N S
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Nucleotide
*OMIM*Protein
*UniGene
*Substance via MeSH
*Genetics Home Reference
Medline Plus Health Information
*Huntington's Disease

ORIGINAL ARTICLE

Replication of twelve association studies for Huntington’s disease residual age of onset in large Venezuelan kindreds

J M Andresen1, J Gayán2, S S Cherny3, D Brocklebank2, G Alkorta-Aranburu1, E A Addis1 The US-Venezuela Collaborative Research Group, L R Cardon2, D E Housman1, N S Wexler4

1 Massachusetts Institute of Technology, Cambridge, Massachusetts, USA
2 Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK
3 Department of Psychiatry and Genome Research Centre, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong
4 Columbia University, New York, New York, USA

Correspondence to:
Dr J M Andresen
Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA; jma{at}mit.edu] Background: The major determinant of age of onset in Huntington’s disease is the length of the causative triplet CAG repeat. Significant variance remains, however, in residual age of onset even after repeat length is factored out. Many genetic polymorphisms have previously shown evidence of association with age of onset of Huntington’s disease in several different populations.

Objective: To replicate these genetic association tests in 443 affected people from a large set of kindreds from Venezuela.

Methods: Previously tested polymorphisms were analysed in the HD gene itself (HD), the GluR6 kainate glutamate receptor (GRIK2), apolipoprotein E (APOE), the transcriptional coactivator CA150 (TCERG1), the ubiquitin carboxy-terminal hydrolase L1 (UCHL1), p53 (TP53), caspase-activated DNase (DFFB), and the NR2A and NR2B glutamate receptor subunits (GRIN2A, GRIN2B).

Results: The GRIN2A single-nucleotide polymorphism explains a small but considerable amount of additional variance in residual age of onset in our sample. The TCERG1 microsatellite shows a trend towards association but does not reach statistical significance, perhaps because of the uninformative nature of the polymorphism caused by extreme allele frequencies. We did not replicate the genetic association of any of the other genes.

Conclusions: GRIN2A and TCERG1 may show true association with residual age of onset for Huntington’s disease. The most surprising negative result is for the GRIK2 (TAA)n polymorphism, which has previously shown association with age of onset in four independent populations with Huntington’s disease. The lack of association in the Venezuelan kindreds may be due to the extremely low frequency of the key (TAA)16 allele in this population.


Abbreviations: PCR, polymerase chain reaction; QTDT, Quantitative Transmission Disequilibrium Test; SNP, single-nucleotide polymorphism




This article has been cited by other articles:


Home page
Hum Mol GenetHome page
S. Metzger, J. Rong, H.-P. Nguyen, A. Cape, J. Tomiuk, A. S. Soehn, P. Propping, Y. Freudenberg-Hua, J. Freudenberg, L. Tong, et al.
Huntingtin-associated protein-1 is a modifier of the age-at-onset of Huntington's disease
Hum. Mol. Genet., April 15, 2008; 17(8): 1137 - 1146.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. L. Pearson, T. J. Robinson, M. J. Munoz, A. R. Kornblihtt, and M. A. Garcia-Blanco
Identification of the Cellular Targets of the Transcription Factor TCERG1 Reveals a Prevalent Role in mRNA Processing
J. Biol. Chem., March 21, 2008; 283(12): 7949 - 7961.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2007 by the BMJ Publishing Group Ltd.